TCRX compared with PASG: revenue, margins and what each company keeps, and the suppliers and customers both name

TCRXTScan Therapeutics, Inc.

Mkt capRevenueRevenue

PASGPassage BIO, Inc.

Mkt capRevenueRevenue

Compare

TCRXTScan Therapeutics, Inc.

PASGPassage BIO, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TCRX1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−0.49%—

PASG

No earnings history for PASG.

= impliedTCRX realized, solidPASG realized, hatchedOne scale, both sides: full bar = 1%× = |realized| ÷ impliedSource: market data

TCRXTScan Therapeutics, Inc.

0.18▲+1.10%· post 0.18

Mkt cap$12.7MRevenue$1MQ2 FY26Revenue$10MFY25

PASGPassage BIO, Inc.

3.90▲+12.72%· post 3.94

ClosedNov 6 '26

Mkt cap$12.8MRevenue$99,000Q3 FY24Revenue—

Compare

ClosedNov 6 '26

TCRXTScan Therapeutics, Inc.

PASGPassage BIO, Inc.

0.18▲+1.10%post 0.18

Price

3.90▲+12.72%post 3.94

$12.7M

Mkt cap

$12.8M

Q2 FY26$1M

Revenue

$99,000Q3 FY24

FY25$10M

Revenue

—

TCRX0.18▲+1.10%vsPASG3.90▲+12.72%ClosedNov 6 '26